{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T13:34:16Z","timestamp":1781789656870,"version":"3.54.5"},"reference-count":24,"publisher":"American Association for Cancer Research (AACR)","issue":"14","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,7,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Breast cancer commonly causes osteolytic metastases in bone, a process that is dependent on tumor-stromal interaction. Proteases play an important role in modulating tumor-stromal interactions in a manner that favors tumor establishment and progression. Whereas several studies have examined the role of proteases in modulating the bone microenvironment, little is currently known about their role in tumor-bone interaction during osteolytic metastasis. In cancer-induced osteolytic lesions, cleavage of receptor activator of nuclear factor-\u03baB ligand (RANKL) to a soluble version (sRANKL) is critical for widespread osteoclast activation. Using a mouse model that mimics osteolytic changes associated with breast cancer\u2013induced bone metastases, we identified cathepsin G, cathepsin K, matrix metalloproteinase (MMP)-9, and MMP13 to be proteases that are up-regulated at the tumor-bone interface using comparative cDNA microarray analysis and quantitative reverse transcription-PCR. Moreover, we showed that cathepsin G is capable of shedding the extracellular domain of RANKL, generating active sRANKL that is capable of inducing differentiation and activation of osteoclast precursors. The major source of cathepsin G at the tumor-bone interface seems to be osteoclasts that up-regulate production of cathepsin G via interaction with tumor cells. Furthermore, we showed that in vitro osteoclastogenesis is reduced by inhibition of cathepsin G in a coculture model and that in vivo inhibition of cathepsin G reduces mammary tumor\u2013induced osteolysis. Together, our data indicate that cathepsin G activity at the tumor-bone interface plays an important role in mammary tumor\u2013induced osteolysis and suggest that cathepsin G is a potentially novel therapeutic target in the treatment of breast cancer bone metastasis. [Cancer Res 2008;68(14):5803\u201311]<\/jats:p>","DOI":"10.1158\/0008-5472.can-07-5889","type":"journal-article","created":{"date-parts":[[2008,7,16]],"date-time":"2008-07-16T04:19:59Z","timestamp":1216181999000},"page":"5803-5811","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":84,"title":["Cathepsin G Enhances Mammary Tumor\u2013Induced Osteolysis by Generating Soluble Receptor Activator of Nuclear Factor-\u03baB Ligand"],"prefix":"10.1158","volume":"68","author":[{"given":"Thomas J.","family":"Wilson","sequence":"first","affiliation":[{"name":"1Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalyan C.","family":"Nannuru","sequence":"additional","affiliation":[{"name":"1Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuru","family":"Futakuchi","sequence":"additional","affiliation":[{"name":"2Department of Experimental Pathology and Tumor Biology, Graduate School of Medical Sciences, Nagoya City University, Nagoya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anguraj","family":"Sadanandam","sequence":"additional","affiliation":[{"name":"1Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh K.","family":"Singh","sequence":"additional","affiliation":[{"name":"1Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2008,7,15]]},"reference":[{"key":"2022061700271489200_B1","doi-asserted-by":"crossref","unstructured":"Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin\u20082007; 57: 43\u201366.","DOI":"10.3322\/canjclin.57.1.43"},{"key":"2022061700271489200_B2","doi-asserted-by":"crossref","unstructured":"Mundy GR. Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer\u20082002; 2: 584\u201393.","DOI":"10.1038\/nrc867"},{"key":"2022061700271489200_B3","doi-asserted-by":"crossref","unstructured":"Kajita M, Itoh Y, Chiba T, et al. Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration. J Cell Biol\u20082001; 153: 893\u2013904.","DOI":"10.1083\/jcb.153.5.893"},{"key":"2022061700271489200_B4","unstructured":"Eliceiri BP, Cheresh DA. Role of \u03b1v integrins during angiogenesis. Cancer J\u20082000; 6 Suppl 3: S245\u20139."},{"key":"2022061700271489200_B5","doi-asserted-by":"crossref","unstructured":"Deryugina EI, Ratnikov BI, Postnova TI, Rozanov DV, Strongin AY. Processing of integrin \u03b1v subunit by membrane type 1 matrix metalloproteinase stimulates migration of breast carcinoma cells on vitronectin and enhances tyrosine phosphorylation of focal adhesion kinase. J Biol Chem\u20082002; 277: 9749\u201356.","DOI":"10.1074\/jbc.M110269200"},{"key":"2022061700271489200_B6","doi-asserted-by":"crossref","unstructured":"Lynch CC, Hikosaka A, Acuff HB, et al. MMP-7 promotes prostate cancer-induced osteolysis via the solubilization of RANKL. Cancer Cell\u20082005; 7: 485\u201396.","DOI":"10.1016\/j.ccr.2005.04.013"},{"key":"2022061700271489200_B7","doi-asserted-by":"crossref","unstructured":"Overall CM, Blobel CP. In search of partners: linking extracellular proteases to substrates. Nat Rev Mol Cell Biol\u20082007; 8: 245\u201357.","DOI":"10.1038\/nrm2120"},{"key":"2022061700271489200_B8","doi-asserted-by":"crossref","unstructured":"Selak MA, Chignard M, Smith JB. Cathepsin G is a strong platelet agonist released by neutrophils. Biochem J\u20081988; 251: 293\u20139.","DOI":"10.1042\/bj2510293"},{"key":"2022061700271489200_B9","doi-asserted-by":"crossref","unstructured":"Yu Q, Stamenkovic I. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-\u03b2 and promotes tumor invasion and angiogenesis. Genes Dev\u20082000; 14: 163\u201376.","DOI":"10.1101\/gad.14.2.163"},{"key":"2022061700271489200_B10","doi-asserted-by":"crossref","unstructured":"Ishikawa T, Kamiyama M, Tani-Ishii N, et al. Inhibition of osteoclast differentiation and bone resorption by cathepsin K antisense oligonucleotides. Mol Carcinog\u20082001; 32: 84\u201391.","DOI":"10.1002\/mc.1067"},{"key":"2022061700271489200_B11","doi-asserted-by":"crossref","unstructured":"Nemeth JA, Yousif R, Herzog M, et al. Matrix metalloproteinase activity, bone matrix turnover, and tumor cell proliferation in prostate cancer bone metastasis. J Natl Cancer Inst\u20082002; 94: 17\u201325.","DOI":"10.1093\/jnci\/94.1.17"},{"key":"2022061700271489200_B12","doi-asserted-by":"crossref","unstructured":"Ishibashi O, Niwa S, Kadoyama K, Inui T. MMP-9 antisense oligodeoxynucleotide exerts an inhibitory effect on osteoclastic bone resorption by suppressing cell migration. Life Sci\u20082006; 79: 1657\u201360.","DOI":"10.1016\/j.lfs.2006.05.024"},{"key":"2022061700271489200_B13","doi-asserted-by":"crossref","unstructured":"Jimi E, Aoki K, Saito H, et al. Selective inhibition of NF-\u03baB blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo. Nat Med\u20082004; 10: 617\u201324.","DOI":"10.1038\/nm1054"},{"key":"2022061700271489200_B14","doi-asserted-by":"crossref","unstructured":"Ohshiba T, Miyaura C, Inada M, Ito A. Role of RANKL-induced osteoclast formation and MMP-dependent matrix degradation in bone destruction by breast cancer metastasis. Br J Cancer\u20082003; 88: 1318\u201326.","DOI":"10.1038\/sj.bjc.6600858"},{"key":"2022061700271489200_B15","doi-asserted-by":"crossref","unstructured":"Yasuda H, Shima N, Nakagawa N, et al. Osteoclast differentiation factor is a ligand for osteoprotegerin\/osteoclastogenesis-inhibitory factor and is identical to TRANCE\/RANKL. Proc Natl Acad Sci U S A\u20081998; 95: 3597\u2013602.","DOI":"10.1073\/pnas.95.7.3597"},{"key":"2022061700271489200_B16","doi-asserted-by":"crossref","unstructured":"Lacey DL, Timms E, Tan HL, et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell\u20081998; 93: 165\u201376.","DOI":"10.1016\/S0092-8674(00)81569-X"},{"key":"2022061700271489200_B17","doi-asserted-by":"crossref","unstructured":"Fujisaki K, Tanabe N, Suzuki N, et al. Receptor activator of NF-\u03baB ligand induces the expression of carbonic anhydrase II, cathepsin K, and matrix metalloproteinase-9 in osteoclast precursor RAW264.7 cells. Life Sci\u20082007; 80: 1311\u20138.","DOI":"10.1016\/j.lfs.2006.12.037"},{"key":"2022061700271489200_B18","doi-asserted-by":"crossref","unstructured":"Chesneau V, Becherer JD, Zheng Y, Erdjument-Bromage H, Tempst P, Blobel CP. Catalytic properties of ADAM19. J Biol Chem\u20082003; 278: 22331\u201340.","DOI":"10.1074\/jbc.M302781200"},{"key":"2022061700271489200_B19","doi-asserted-by":"crossref","unstructured":"Schlondorff J, Lum L, Blobel CP. Biochemical and pharmacologic criteria define two shedding activities for TRANCE\/OPGL that are distinct from the tumor necrosis factor \u03b1 convertase. J Biol Chem\u20082001; 276: 14665\u201374.","DOI":"10.1074\/jbc.M010741200"},{"key":"2022061700271489200_B20","doi-asserted-by":"crossref","unstructured":"Szekanecz Z, Koch AE. Macrophages and their products in rheumatoid arthritis. Curr Opin Rheumatol\u20082007; 19: 289\u201395.","DOI":"10.1097\/BOR.0b013e32805e87ae"},{"key":"2022061700271489200_B21","doi-asserted-by":"crossref","unstructured":"Chavan V, Patil N, Karnik ND. Study of leukocytic hydrolytic enzymes in patients with acute stage of coronary heart disease. Indian J Med Sci\u20082007; 61: 73\u201382.","DOI":"10.4103\/0019-5359.30347"},{"key":"2022061700271489200_B22","doi-asserted-by":"crossref","unstructured":"Komine K, Kuroishi T, Ozawa A, et al. Cleaved inflammatory lactoferrin peptides in parotid saliva of periodontitis patients. Mol Immunol\u20082007; 44: 1498\u2013508.","DOI":"10.1016\/j.molimm.2006.09.003"},{"key":"2022061700271489200_B23","doi-asserted-by":"crossref","unstructured":"Shimoda N, Fukazawa N, Nonomura K, Fairchild RL. Cathepsin g is required for sustained inflammation and tissue injury after reperfusion of ischemic kidneys. Am J Pathol\u20082007; 170: 930\u201340.","DOI":"10.2353\/ajpath.2007.060486"},{"key":"2022061700271489200_B24","doi-asserted-by":"crossref","unstructured":"Campbell EJ, Owen CA. The sulfate groups of chondroitin sulfate- and heparan sulfate-containing proteoglycans in neutrophil plasma membranes are novel binding sites for human leukocyte elastase and cathepsin G. J Biol Chem\u20082007; 282: 14645\u201354.","DOI":"10.1074\/jbc.M608346200"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/68\/14\/5803\/2597823\/5803.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/68\/14\/5803\/2597823\/5803.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T04:48:02Z","timestamp":1655441282000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/68\/14\/5803\/541692\/Cathepsin-G-Enhances-Mammary-Tumor-Induced"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7,15]]},"references-count":24,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2008,7,15]]},"published-print":{"date-parts":[[2008,7,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-07-5889","relation":{},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7,15]]}}}